Home / Stocks / PODD

Insulet (PODD, Health Care Equipment) Stock Valuation & Fair Value Quality business with a solid forward outlook

Insulet (PODD, Health Care Equipment) trades at a blended P/E of 24.7, about 91% below its historical normal valuation, with a forward growth estimate of 20.2% and a PEG of 1.22.

DATA AS OF 2026-08-21
Blended P/E
24.7
Normal P/E
278.2
PEG
1.22
Fwd growth
20.2%
Div yield
0.0%
RSI (14)
45.6
Neutral

The Street vs SeerForecast

Wall Street's mean price target for PODD is $171.91 across 22 analysts, 16.0% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been quality business with a solid forward outlook since 2026-06-03.

Price and rating by weekClose moved +0.0 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Quality business with a solid forward outlook, close 143.30 (recalculated)2026-06-10: Quality business with a solid forward outlook, close 150.71 (recalculated)2026-06-14: Quality business with a solid forward outlook, close 149.70 (recalculated)2026-06-16: Quality business with a solid forward outlook, close 147.69 (recalculated)2026-06-21: Quality business with a solid forward outlook, close 145.76 (recalculated)2026-07-02: Quality business with a solid forward outlook, close 164.48 (recalculated)2026-07-06: Quality business with a solid forward outlook, close 159.77 (recalculated)2026-07-09: Quality business with a solid forward outlook, close 158.29 (recalculated)2026-07-12: Quality business with a solid forward outlook, close 161.28 (recalculated)2026-07-13: Quality business with a solid forward outlook, close 162.06 (recalculated)2026-07-14: Quality business with a solid forward outlook, close 159.12 (recalculated)2026-07-20: Quality business with a solid forward outlook, close 167.37 (recalculated)2026-07-22: Quality business with a solid forward outlook, close 158.93 (recalculated)2026-07-25: Quality business with a solid forward outlook, close 163.26 (recalculated)2026-07-27: Quality business with a solid forward outlook, close 165.00 (recalculated)2026-07-31: Quality business with a solid forward outlook, close 165.35 (recalculated)2026-08-03: Quality business with a solid forward outlook, close 165.352026-08-07: Quality business with a solid forward outlook, close 141.17 (recalculated)2026-08-10: Quality business with a solid forward outlook, close 141.172026-08-14: Quality business with a solid forward outlook, close 143.34 (recalculated)2026-08-17: Quality business with a solid forward outlook, close 143.341431432026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 25.6-91%Quality business with a solid forward outlook
2026-06-10P/E 27.3-90%Quality business with a solid forward outlook
2026-06-14P/E 27.3-90%Quality business with a solid forward outlook
2026-06-16P/E 27.3-90%Quality business with a solid forward outlook
2026-06-21P/E 27.3-90%Quality business with a solid forward outlook
2026-07-02P/E 27.9-90%Quality business with a solid forward outlook
2026-07-06P/E 28.7-90%Quality business with a solid forward outlook
2026-07-09P/E 28.7-90%Quality business with a solid forward outlook
2026-07-12P/E 28.0-90%Quality business with a solid forward outlook
2026-07-13P/E 28.0-90%Quality business with a solid forward outlook
2026-07-14P/E 28.0-90%Quality business with a solid forward outlook
2026-07-20P/E 28.4-90%Quality business with a solid forward outlook
2026-07-22P/E 28.4-90%Quality business with a solid forward outlook
2026-07-25P/E 28.1-90%Quality business with a solid forward outlook
2026-07-27P/E 28.1-90%Quality business with a solid forward outlook
2026-07-31P/E 28.4-90%Quality business with a solid forward outlook
2026-08-03P/E 28.3-90%Quality business with a solid forward outlook
2026-08-07P/E 23.6-92%Quality business with a solid forward outlook
2026-08-10P/E 23.9-91%Quality business with a solid forward outlook
2026-08-14P/E 24.7-91%Quality business with a solid forward outlook
2026-08-17P/E 24.2-91%Quality business with a solid forward outlook
2026-08-21P/E 24.7-91%Quality business with a solid forward outlook ← now

Frequently asked questions

Is Insulet stock overvalued?

At a blended P/E of 24.7 versus its historical normal P/E of 278.2, Insulet trades about 91% below its typical valuation, with a PEG of 1.22 on 20.2% forward growth. tickerseer currently rates it quality business with a solid forward outlook.

What is Insulet's fair value and PEG?

Insulet trades at a blended P/E of 24.7 against a historical normal P/E of 278.2, a PEG of 1.22, and a forward growth estimate of 20.2%.

Has tickerseer's rating of Insulet changed?

tickerseer's rating has been quality business with a solid forward outlook since 2026-06-03.

What is the analyst price target for Insulet?

The mean Wall Street price target for Insulet is $171.91 across 22 analysts, 16.0% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track PODD free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.